Structure

Physi-Chem Properties

Molecular Weight:  446.25
Volume:  493.267
LogP:  7.986
LogD:  5.106
LogS:  -2.398
# Rotatable Bonds:  8
TPSA:  73.83
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.307
Synthetic Accessibility Score:  3.235
Fsp3:  0.31
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.022
MDCK Permeability:  1.912598600029014e-05
Pgp-inhibitor:  0.731
Pgp-substrate:  0.544
Human Intestinal Absorption (HIA):  0.015
20% Bioavailability (F20%):  0.996
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.005
Plasma Protein Binding (PPB):  97.63915252685547%
Volume Distribution (VD):  3.198
Pgp-substrate:  2.8777246475219727%

ADMET: Metabolism

CYP1A2-inhibitor:  0.928
CYP1A2-substrate:  0.179
CYP2C19-inhibitor:  0.945
CYP2C19-substrate:  0.059
CYP2C9-inhibitor:  0.702
CYP2C9-substrate:  0.974
CYP2D6-inhibitor:  0.914
CYP2D6-substrate:  0.846
CYP3A4-inhibitor:  0.358
CYP3A4-substrate:  0.087

ADMET: Excretion

Clearance (CL):  9.348
Half-life (T1/2):  0.19

ADMET: Toxicity

hERG Blockers:  0.098
Human Hepatotoxicity (H-HT):  0.953
Drug-inuced Liver Injury (DILI):  0.271
AMES Toxicity:  0.011
Rat Oral Acute Toxicity:  0.054
Maximum Recommended Daily Dose:  0.889
Skin Sensitization:  0.903
Carcinogencity:  0.041
Eye Corrosion:  0.003
Eye Irritation:  0.346
Respiratory Toxicity:  0.871

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC297531

Natural Product ID:  NPC297531
Common Name*:   Mulberrofuran D
IUPAC Name:   5-[7-[(2E)-3,7-dimethylocta-2,6-dienyl]-6-hydroxy-1-benzofuran-2-yl]-4-(3-methylbut-2-enyl)benzene-1,3-diol
Synonyms:   Mulberrofuran D
Standard InCHIKey:  WCJPAQJEARHLGS-KEBDBYFISA-N
Standard InCHI:  InChI=1S/C29H34O4/c1-18(2)7-6-8-20(5)10-13-24-26(31)14-11-21-15-28(33-29(21)24)25-16-22(30)17-27(32)23(25)12-9-19(3)4/h7,9-11,14-17,30-32H,6,8,12-13H2,1-5H3/b20-10+
SMILES:  C/C(=CCc1c(O)ccc2c1oc(c2)c1cc(O)cc(c1CC=C(C)C)O)/CCC=C(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL517247
PubChem CID:   5467256
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. PMID[11429996]
NPO2578 Morus sp. Species Sulidae Eukaryota n.a. n.a. n.a. PMID[19072214]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO2578 Morus sp. Species Sulidae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO9402 Morus mongolica Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT924 Cell Line HSC-2 Homo sapiens CC50 = 83000.0 nM PMID[514002]
NPT211 Individual Protein Hypoxia-inducible factor 1 alpha Homo sapiens IC50 = 4050.0 nM PMID[514003]
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens Km = 2080000.0 nM PMID[514004]
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 = 4300.0 nM PMID[514004]
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens Vmax = 5.78 microM/min PMID[514004]
NPT1120 Individual Protein Pancreatic triacylglycerol lipase Sus scrofa IC50 = 90.0 nM PMID[514005]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. CC50 = 74000.0 nM PMID[514002]
NPT27 Others Unspecified CC50 = 81000.0 nM PMID[514002]
NPT27 Others Unspecified Ratio = 1.0 n.a. PMID[514002]
NPT20904 CELL-LINE Hep 3B2 Homo sapiens IC50 = 2170.0 nM PMID[514003]
NPT21802 PROTEIN FAMILY Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha Homo sapiens IC50 = 8760.0 nM PMID[514003]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC297531 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC213936
0.9932 High Similarity NPC235333
0.9865 High Similarity NPC148938
0.9864 High Similarity NPC142308
0.9796 High Similarity NPC23668
0.9796 High Similarity NPC193976
0.9733 High Similarity NPC164110
0.9733 High Similarity NPC246647
0.9733 High Similarity NPC96342
0.9733 High Similarity NPC268360
0.9733 High Similarity NPC212967
0.973 High Similarity NPC207624
0.9728 High Similarity NPC78335
0.9728 High Similarity NPC230713
0.9667 High Similarity NPC180924
0.9662 High Similarity NPC106372
0.9662 High Similarity NPC115324
0.9662 High Similarity NPC170169
0.9662 High Similarity NPC58668
0.966 High Similarity NPC178202
0.96 High Similarity NPC99199
0.9533 High Similarity NPC472462
0.9527 High Similarity NPC226644
0.9527 High Similarity NPC37226
0.947 High Similarity NPC198490
0.9463 High Similarity NPC167576
0.9459 High Similarity NPC135325
0.9456 High Similarity NPC210826
0.9423 High Similarity NPC53640
0.9404 High Similarity NPC213608
0.9404 High Similarity NPC183874
0.9404 High Similarity NPC1477
0.9392 High Similarity NPC12148
0.9392 High Similarity NPC17816
0.9392 High Similarity NPC130581
0.9388 High Similarity NPC155144
0.9338 High Similarity NPC5871
0.9333 High Similarity NPC13282
0.9324 High Similarity NPC51641
0.9324 High Similarity NPC300267
0.932 High Similarity NPC225884
0.9281 High Similarity NPC160015
0.9281 High Similarity NPC247677
0.9276 High Similarity NPC72370
0.9267 High Similarity NPC221868
0.9267 High Similarity NPC39929
0.9267 High Similarity NPC65775
0.9267 High Similarity NPC37208
0.9267 High Similarity NPC296030
0.9267 High Similarity NPC10027
0.9257 High Similarity NPC98926
0.9257 High Similarity NPC230943
0.9221 High Similarity NPC260902
0.9221 High Similarity NPC296957
0.9221 High Similarity NPC65504
0.9205 High Similarity NPC227122
0.92 High Similarity NPC272194
0.9189 High Similarity NPC302181
0.9161 High Similarity NPC40583
0.9161 High Similarity NPC476350
0.9161 High Similarity NPC244750
0.9161 High Similarity NPC476349
0.9156 High Similarity NPC137100
0.9145 High Similarity NPC258249
0.9139 High Similarity NPC223988
0.9122 High Similarity NPC53192
0.9119 High Similarity NPC253730
0.9119 High Similarity NPC286230
0.9114 High Similarity NPC39306
0.9103 High Similarity NPC304839
0.9103 High Similarity NPC220582
0.9103 High Similarity NPC260296
0.9103 High Similarity NPC115432
0.9085 High Similarity NPC253872
0.9085 High Similarity NPC263676
0.9085 High Similarity NPC67654
0.9073 High Similarity NPC37135
0.9073 High Similarity NPC186397
0.9057 High Similarity NPC277480
0.9054 High Similarity NPC49108
0.9051 High Similarity NPC159508
0.9051 High Similarity NPC133065
0.9045 High Similarity NPC30655
0.9045 High Similarity NPC45124
0.9045 High Similarity NPC74854
0.9026 High Similarity NPC178964
0.9026 High Similarity NPC122365
0.9026 High Similarity NPC210942
0.9026 High Similarity NPC95842
0.9026 High Similarity NPC280530
0.9026 High Similarity NPC169990
0.902 High Similarity NPC116604
0.902 High Similarity NPC156244
0.9013 High Similarity NPC266499
0.9013 High Similarity NPC158338
0.9013 High Similarity NPC65589
0.9013 High Similarity NPC288036
0.9013 High Similarity NPC97029
0.9013 High Similarity NPC317492
0.9013 High Similarity NPC97028
0.9013 High Similarity NPC100985
0.9 High Similarity NPC247973
0.9 High Similarity NPC50394
0.8994 High Similarity NPC169471
0.8994 High Similarity NPC37183
0.8994 High Similarity NPC474591
0.8993 High Similarity NPC226942
0.8993 High Similarity NPC470636
0.8993 High Similarity NPC96791
0.8987 High Similarity NPC3448
0.8987 High Similarity NPC84515
0.8987 High Similarity NPC193998
0.8987 High Similarity NPC312056
0.8987 High Similarity NPC477239
0.8961 High Similarity NPC40356
0.8961 High Similarity NPC154683
0.8957 High Similarity NPC227906
0.8947 High Similarity NPC7025
0.8947 High Similarity NPC145467
0.8947 High Similarity NPC168085
0.8947 High Similarity NPC256672
0.8947 High Similarity NPC27221
0.8947 High Similarity NPC39195
0.8933 High Similarity NPC262935
0.8933 High Similarity NPC251182
0.8933 High Similarity NPC172182
0.8931 High Similarity NPC155640
0.8924 High Similarity NPC304387
0.8924 High Similarity NPC188486
0.8919 High Similarity NPC472366
0.8917 High Similarity NPC472877
0.8912 High Similarity NPC62735
0.891 High Similarity NPC45131
0.8903 High Similarity NPC329844
0.8896 High Similarity NPC72958
0.8896 High Similarity NPC478148
0.8896 High Similarity NPC474417
0.8896 High Similarity NPC149526
0.8896 High Similarity NPC232645
0.8889 High Similarity NPC269420
0.8889 High Similarity NPC131866
0.8882 High Similarity NPC150215
0.8882 High Similarity NPC123202
0.8882 High Similarity NPC308200
0.8882 High Similarity NPC77903
0.8882 High Similarity NPC7943
0.8882 High Similarity NPC17101
0.8882 High Similarity NPC22005
0.8875 High Similarity NPC136641
0.8874 High Similarity NPC311741
0.8874 High Similarity NPC234629
0.8874 High Similarity NPC29577
0.8868 High Similarity NPC219861
0.8868 High Similarity NPC272722
0.8867 High Similarity NPC144499
0.8867 High Similarity NPC84266
0.8867 High Similarity NPC310340
0.8861 High Similarity NPC470810
0.8859 High Similarity NPC172986
0.8859 High Similarity NPC261227
0.8859 High Similarity NPC69769
0.8859 High Similarity NPC275734
0.8859 High Similarity NPC28337
0.8859 High Similarity NPC270883
0.8854 High Similarity NPC196448
0.8854 High Similarity NPC236796
0.8854 High Similarity NPC273843
0.8846 High Similarity NPC66508
0.8846 High Similarity NPC55662
0.8846 High Similarity NPC166054
0.8846 High Similarity NPC254351
0.8846 High Similarity NPC226656
0.8839 High Similarity NPC130015
0.8839 High Similarity NPC217447
0.8839 High Similarity NPC38361
0.8839 High Similarity NPC125300
0.8839 High Similarity NPC41326
0.8839 High Similarity NPC474843
0.8839 High Similarity NPC87708
0.8831 High Similarity NPC295036
0.8831 High Similarity NPC470107
0.8831 High Similarity NPC202595
0.8831 High Similarity NPC476185
0.8831 High Similarity NPC321896
0.8831 High Similarity NPC472406
0.8831 High Similarity NPC119929
0.8831 High Similarity NPC472421
0.8831 High Similarity NPC101957
0.8831 High Similarity NPC120105
0.8824 High Similarity NPC105415
0.8824 High Similarity NPC216624
0.8816 High Similarity NPC290133
0.8816 High Similarity NPC187282
0.8816 High Similarity NPC24136
0.8816 High Similarity NPC299011
0.8816 High Similarity NPC477955
0.8816 High Similarity NPC237208
0.8812 High Similarity NPC38591
0.8812 High Similarity NPC109180
0.8812 High Similarity NPC472581

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC297531 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8854 High Similarity NPD3749 Approved
0.8782 High Similarity NPD7819 Suspended
0.875 High Similarity NPD4378 Clinical (unspecified phase)
0.8658 High Similarity NPD2344 Approved
0.8627 High Similarity NPD7410 Clinical (unspecified phase)
0.8571 High Similarity NPD6959 Discontinued
0.8544 High Similarity NPD2393 Clinical (unspecified phase)
0.8543 High Similarity NPD2800 Approved
0.8506 High Similarity NPD2533 Approved
0.8506 High Similarity NPD2532 Approved
0.8506 High Similarity NPD2534 Approved
0.8491 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8476 Intermediate Similarity NPD7473 Discontinued
0.8438 Intermediate Similarity NPD3882 Suspended
0.8431 Intermediate Similarity NPD2309 Approved
0.8421 Intermediate Similarity NPD1243 Approved
0.8405 Intermediate Similarity NPD6232 Discontinued
0.8397 Intermediate Similarity NPD920 Approved
0.8378 Intermediate Similarity NPD1240 Approved
0.8355 Intermediate Similarity NPD1549 Phase 2
0.8333 Intermediate Similarity NPD6559 Discontinued
0.8323 Intermediate Similarity NPD7768 Phase 2
0.8323 Intermediate Similarity NPD1511 Approved
0.8313 Intermediate Similarity NPD2801 Approved
0.8302 Intermediate Similarity NPD7411 Suspended
0.8289 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8289 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8282 Intermediate Similarity NPD5494 Approved
0.8278 Intermediate Similarity NPD1510 Phase 2
0.8272 Intermediate Similarity NPD7075 Discontinued
0.8269 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8267 Intermediate Similarity NPD1607 Approved
0.825 Intermediate Similarity NPD1934 Approved
0.8247 Intermediate Similarity NPD3750 Approved
0.8242 Intermediate Similarity NPD3926 Phase 2
0.8239 Intermediate Similarity NPD4380 Phase 2
0.8235 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8224 Intermediate Similarity NPD2796 Approved
0.8217 Intermediate Similarity NPD1512 Approved
0.8199 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8193 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD3226 Approved
0.8158 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8141 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8121 Intermediate Similarity NPD1247 Approved
0.8105 Intermediate Similarity NPD2935 Discontinued
0.8095 Intermediate Similarity NPD3818 Discontinued
0.8089 Intermediate Similarity NPD7390 Discontinued
0.8052 Intermediate Similarity NPD2346 Discontinued
0.8047 Intermediate Similarity NPD5844 Phase 1
0.8039 Intermediate Similarity NPD2799 Discontinued
0.8 Intermediate Similarity NPD919 Approved
0.7976 Intermediate Similarity NPD6166 Phase 2
0.7976 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7976 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD6799 Approved
0.7964 Intermediate Similarity NPD7229 Phase 3
0.7949 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7935 Intermediate Similarity NPD1471 Phase 3
0.7922 Intermediate Similarity NPD3748 Approved
0.7914 Intermediate Similarity NPD6801 Discontinued
0.7901 Intermediate Similarity NPD6599 Discontinued
0.7879 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7871 Intermediate Similarity NPD6100 Approved
0.7871 Intermediate Similarity NPD6099 Approved
0.7866 Intermediate Similarity NPD1465 Phase 2
0.7857 Intermediate Similarity NPD5711 Approved
0.7857 Intermediate Similarity NPD5710 Approved
0.7836 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7836 Intermediate Similarity NPD7286 Phase 2
0.7821 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD2296 Approved
0.7818 Intermediate Similarity NPD3817 Phase 2
0.7797 Intermediate Similarity NPD4287 Approved
0.7792 Intermediate Similarity NPD6651 Approved
0.7791 Intermediate Similarity NPD7074 Phase 3
0.7778 Intermediate Similarity NPD943 Approved
0.7763 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7763 Intermediate Similarity NPD2313 Discontinued
0.7759 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7756 Intermediate Similarity NPD1551 Phase 2
0.7746 Intermediate Similarity NPD5953 Discontinued
0.7733 Intermediate Similarity NPD7054 Approved
0.7697 Intermediate Similarity NPD4625 Phase 3
0.7688 Intermediate Similarity NPD7472 Approved
0.7674 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD3764 Approved
0.7643 Intermediate Similarity NPD5405 Approved
0.7643 Intermediate Similarity NPD5404 Approved
0.7643 Intermediate Similarity NPD5406 Approved
0.7643 Intermediate Similarity NPD5408 Approved
0.7605 Intermediate Similarity NPD5402 Approved
0.76 Intermediate Similarity NPD7251 Discontinued
0.758 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7557 Intermediate Similarity NPD7808 Phase 3
0.755 Intermediate Similarity NPD1203 Approved
0.755 Intermediate Similarity NPD1470 Approved
0.7545 Intermediate Similarity NPD5761 Phase 2
0.7545 Intermediate Similarity NPD5760 Phase 2
0.7543 Intermediate Similarity NPD6797 Phase 2
0.7532 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD8313 Approved
0.7514 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD8312 Approved
0.75 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD8434 Phase 2
0.7485 Intermediate Similarity NPD6280 Approved
0.7485 Intermediate Similarity NPD6279 Approved
0.7458 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD4628 Phase 3
0.7443 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD6832 Phase 2
0.7403 Intermediate Similarity NPD4908 Phase 1
0.7401 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD1201 Approved
0.7394 Intermediate Similarity NPD5403 Approved
0.7389 Intermediate Similarity NPD447 Suspended
0.7386 Intermediate Similarity NPD1729 Discontinued
0.7386 Intermediate Similarity NPD2798 Approved
0.7384 Intermediate Similarity NPD7199 Phase 2
0.7378 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD3751 Discontinued
0.7351 Intermediate Similarity NPD9717 Approved
0.7351 Intermediate Similarity NPD1608 Approved
0.7346 Intermediate Similarity NPD7003 Approved
0.7341 Intermediate Similarity NPD6808 Phase 2
0.7308 Intermediate Similarity NPD3268 Approved
0.7299 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD4361 Phase 2
0.7294 Intermediate Similarity NPD4288 Approved
0.7292 Intermediate Similarity NPD8151 Discontinued
0.7284 Intermediate Similarity NPD2654 Approved
0.7278 Intermediate Similarity NPD230 Phase 1
0.7278 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD37 Approved
0.7273 Intermediate Similarity NPD7177 Discontinued
0.7273 Intermediate Similarity NPD5401 Approved
0.7267 Intermediate Similarity NPD6234 Discontinued
0.7251 Intermediate Similarity NPD4966 Approved
0.7251 Intermediate Similarity NPD4965 Approved
0.7251 Intermediate Similarity NPD4967 Phase 2
0.7243 Intermediate Similarity NPD4360 Phase 2
0.7243 Intermediate Similarity NPD4363 Phase 3
0.7241 Intermediate Similarity NPD3787 Discontinued
0.7219 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD2797 Approved
0.7208 Intermediate Similarity NPD1164 Approved
0.72 Intermediate Similarity NPD1651 Approved
0.7197 Intermediate Similarity NPD411 Approved
0.7179 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7173 Intermediate Similarity NPD7871 Phase 2
0.7173 Intermediate Similarity NPD7870 Phase 2
0.7171 Intermediate Similarity NPD1610 Phase 2
0.7171 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD422 Phase 1
0.7169 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7166 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD2403 Approved
0.7152 Intermediate Similarity NPD17 Approved
0.7143 Intermediate Similarity NPD6777 Approved
0.7143 Intermediate Similarity NPD1876 Approved
0.7143 Intermediate Similarity NPD7033 Discontinued
0.7143 Intermediate Similarity NPD6776 Approved
0.7143 Intermediate Similarity NPD6782 Approved
0.7143 Intermediate Similarity NPD6780 Approved
0.7143 Intermediate Similarity NPD6779 Approved
0.7143 Intermediate Similarity NPD4308 Phase 3
0.7143 Intermediate Similarity NPD6778 Approved
0.7143 Intermediate Similarity NPD6781 Approved
0.7143 Intermediate Similarity NPD6696 Suspended
0.7143 Intermediate Similarity NPD1283 Approved
0.7143 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD7783 Phase 2
0.7126 Intermediate Similarity NPD6273 Approved
0.7124 Intermediate Similarity NPD3972 Approved
0.712 Intermediate Similarity NPD7697 Approved
0.712 Intermediate Similarity NPD7698 Approved
0.712 Intermediate Similarity NPD7696 Phase 3
0.712 Intermediate Similarity NPD7435 Discontinued
0.7115 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD4060 Phase 1
0.7104 Intermediate Similarity NPD8150 Discontinued
0.7101 Intermediate Similarity NPD7458 Discontinued
0.7093 Intermediate Similarity NPD5616 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD7228 Approved
0.7078 Intermediate Similarity NPD4749 Approved
0.7076 Intermediate Similarity NPD6844 Discontinued
0.7062 Intermediate Similarity NPD4575 Clinical (unspecified phase)
0.7043 Intermediate Similarity NPD3269 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data